Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Sign up for the iNFOnews newsletter today!
Selecting your primary region ensures you get the stories that matter to you first.
SMITHS FALLS, Ont. – Canopy Growth Corp. of Smiths Falls, Ont., has an agreement to buy pharmaceutical distributor MedCann, which has placed the Canadian marijuana company’s Tweed-branded cannabis strains in German pharmacies.
The purchase — subject to approvals — will be made with Canopy shares (TSX:CGC), which on Friday closed at $10.60 on the Toronto Stock Exchange.
At that value, the transaction would be worth about $7.2 million upon closing.
Canopy would also pay up to 490,000 shares over two years if certain performance targets are achieved, bringing the total number of shares to be issued to about 1.16 million — one per cent of Canopy’s current common shares.
Canopy Growth currently has a market value of about $1.2 billion, based on Friday’s stock price.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.